ADP-Glo: A Bioluminescent and homogeneous ADP monitoring assay for kinases

Assay and Drug Development Technologies
Hicham ZegzoutiSaid A Goueli

Abstract

ADP-Glo is a novel bioluminescent, homogeneous assay for monitoring ADP producing biochemical reactions and thus it is an ideal assay for detecting enzyme activity using a wide variety of substrates. It is a universal assay that can be used with protein kinases, lipid kinases, sugar kinases, and many more kinases as well as ATPases. Because of its high sensitivity, it is suitable for monitoring enzyme activities at very early substrate conversions requiring very low amount of enzymes. Furthermore, as the assay is applicable to a broad range of ATP and substrate concentrations, it is optimal for enzymes that require high ATP and substrate concentrations. This is critical since inhibitor potency has to be demonstrated at the cellular level where ATP is present at millimolar concentrations. ADP-Glo is performed in 2 steps upon completion of kinase reaction: a combined termination of kinase reaction and depletion of remaining ATP in the first step, and conversion of generated ADP to ATP and the newly produced ATP to light output using luciferase/luciferin reaction in the second step. The luminescent signal generated is proportional to the ADP concentration produced and is correlated with the kinase activity. Due to its high signal ...Continue Reading

References

Jul 1, 1996·Protein Science : a Publication of the Protein Society·B D GrantS S Taylor
Jan 27, 2000·Cell·T Hunter
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Jun 13, 2001·Methods in Enzymology·S A GoueliB S Goueli
Oct 18, 2001·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·H BazinG Mathis
Jul 18, 2002·Nature Reviews. Drug Discovery·Philip Cohen
Jul 18, 2002·Nature Reviews. Drug Discovery·Margaret A Somerville
Dec 10, 2002·Science·G ManningS Sudarsanam
May 22, 2003·Analytical Biochemistry·Kevin KupchoSaid A Goueli
May 29, 2003·Combinatorial Chemistry & High Throughput Screening·G J R ZamanC A A van Boeckel
May 29, 2004·Assay and Drug Development Technologies·Mitsunori Koresawa, Takayoshi Okabe
Jan 31, 2006·Expert Opinion on Therapeutic Targets·Robert G Lowery, Karen Kleman-Leyer
Jun 6, 2006·Journal of Biomolecular Screening·Neil W CharterRichard M Eglen
Jun 9, 2006·Journal of Biomolecular Screening·Oliver von AhsenKarsten Parczyk
Jan 12, 2007·Cardiovascular Drug Reviews·A Lochner, J A Moolman
Mar 16, 2007·Assay and Drug Development Technologies·Andrea BakiGyörgy M Keserü
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Mar 20, 2009·Quarterly Reviews of Biophysics·Louise N Johnson
Jun 1, 2008·Expert Opinion on Drug Discovery·Haiching MaKurumi Horiuchi
Jan 12, 2010·Assay and Drug Development Technologies·Cordelle TanegaDouglas S Auld

❮ Previous
Next ❯

Citations

Sep 2, 2010·Assay and Drug Development Technologies·James IngleseDouglas Auld
Jun 19, 2014·Journal of Enzyme Inhibition and Medicinal Chemistry·Alexander RoheMatthias Schmidt
Oct 21, 2015·Advances in Biological Regulation·Louis PerdiosMatilda Katan
Dec 12, 2012·Analytical Biochemistry·Sarah J DuellmanJames J Cali
Oct 31, 2014·Journal of Medicinal Chemistry·Jie QinRonen Marmorstein
Dec 18, 2015·Bioorganic & Medicinal Chemistry·Chamara SenevirathneMary Kay H Pflum
Apr 21, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Chih-Hsin LinGuey-Jen Lee-Chen
Nov 22, 2011·Bioorganic & Medicinal Chemistry Letters·Stephen J BoyerMargaret M O'Neill
Dec 13, 2012·Bioorganic & Medicinal Chemistry Letters·Koc-Kan HoSteven B Kanner
Dec 7, 2010·Protein Expression and Purification·Rachel Friedman OhanaMarjeta Urh
Jun 28, 2011·Analytical Biochemistry·Andrew W TaiTamas Balla
Aug 29, 2013·Biochemical and Biophysical Research Communications·Dominik SchröderSabine Windhorst
Jun 29, 2016·Carbohydrate Research·Louis P Conway, Josef Voglmeir
Jun 22, 2016·Analytical Biochemistry·Subhanjan MondalSaid A Goueli
Nov 3, 2016·Frontiers in Cell and Developmental Biology·Richard M EpandMathieu Lemaire
Nov 10, 2011·Journal of Biomolecular Screening·Iva NavratilovaAndrew Cook
Dec 23, 2016·Chembiochem : a European Journal of Chemical Biology·Hachemi KadriYoucef Mehellou
Jan 18, 2017·SLAS Technology·Tracy WorzellaHicham Zegzouti
Apr 25, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Huaiwei DingChunyan Tan
Sep 26, 2017·SLAS Discovery·Stephen A St-GallayJon Winter-Holt
Jul 13, 2018·Chembiochem : a European Journal of Chemical Biology·Mubarak A AlAmriYoucef Mehellou
Jun 6, 2018·The Journal of Infectious Diseases·Liang LiYan Q Xiong
Aug 12, 2018·Molecular Microbiology·Norbert K TavaresJorge C Escalante-Semerena
Jul 2, 2019·Chemical Biology & Drug Design·Rama K MishraLeonidas C Platanias
Mar 5, 2013·Current Protocols in Pharmacology·Krisna C Duong-Ly, Jeffrey R Peterson
Oct 27, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·M Lourdes SciúE Laura Moyano
Nov 21, 2019·Pharmaceuticals·Anne Cecília Nascimento da CruzTeresinha Gonçalves da Silva

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
fluorescence resonance

Software Mentioned

Excel
Adapta
Prism
GraphPad

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.